Abstracts

Abstract submission deadline: October 3, 2022, 11:59PM CST. 
An individual may be the first author on a maximum of three (3) abstracts. 
An individual may be a contributing author on an unlimited number of abstracts. 
All submitted abstracts become the property of MDS.

Format

Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information. 

Abstracts should be arranged as follows:

• Objective
• Background
• Methods
• Results
• Conclusions

*You may submit a case report using the standard abstract format

Do not include any identifying information directly on the abstract. 

Only non-proprietary (generic) drug names should be used and should be written without capitals. 

Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected. 

Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category.

The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands. 

Please note there is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.

To list references, enter the appropriate ID tag. [1] for your first reference, [2] for your second reference, [3] for your third reference, etc. 
 

Abstract submissions must be received by October 3, 2022, 11:59PM CST. 
The sole means of submission is via the Internet. Please do not e-mail, fax, or mail abstract submissions. 

Abstracts must be submitted and presented in English. 
MDS members and non-members are eligible to submit abstracts.
There is no fee for submitting an MDS abstract.
MDS does not offer CME credit for poster viewing or submitted abstracts. 
AOPMC faculty are not required to submit an abstract. 

MDS expects that all accepted abstracts will be presented during the scheduled poster session time during the 8th AOPMC and that no submitted abstracts will be withdrawn. Please do not submit an abstract unless you are prepared to travel to the 8th AOPMC to present your abstract as a printed poster as scheduled by MDS.

All abstract presenters are required to register and pay applicable registration fees to attend the AOPMC.
 

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected. 

Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.

If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and required to revise the abstract, or the abstract will be rejected. 

All abstracts presented at a previous MDS International Congress or MDS regional meeting, such as the AOPMC or PAS Congress, have been published by MDS.

MDS does not republish previously published abstracts. 
 

The AOPMC Scientific Program Committee will review all abstracts in October of 2022. The Committee shall be directed to reject abstracts for the following reasons:

• Plagiarism detected
• Marketing detected 
• Subject not related to the field of Movement Disorders
• Does not meet basic requirements

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected. 
 

All notifications regarding a saved or submitted abstract will be sent only to the person identified as ‘Contact for Official Abstract Correspondence’. It is expected that the designated contact person will circulate updates regarding the abstract as needed. 

All successfully submitted abstracts will receive a confirmation e-mail to the designated contact person. If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site to verify the status of the submission. 

Abstract acceptance notifications will be sent to the designated contact person via e-mail in November 2022.

An official abstract notification letter will be available through the submission site and can be downloaded and printed at any time after notifications have been sent in November 2022.

All confirmed abstract submissions will be reviewed for acceptance by MDS. 

Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS. 

Please ensure that noreply@omnipress.com and aopmc@movementdisorders.org are designated as a “safe sender” to ensure timely correspondence regarding the abstract submission.

Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will come from noreply@omnipress.com or aopmc@movementdisorders.org.

Abstract status can also be checked directly on the submission site in November 2022.
 

July 1, 2022 - October 3, 2022
You may withdraw a submitted abstract at any time while submission is still open (before October 3, 2022). To withdraw an abstract, simply log in to your submission and click on 'Withdraw'. There is no penalty to withdraw your abstract.
 
October 3, 2022 - January 31, 2023 
Requests to withdraw a submitted abstract after the submission deadline (October 3, 2022) must be received in writing by  January 31, 2023, to aopmc@movementdisorders.org.
 
January 31, 2023 - Onward
After January 31, 2023, your abstract cannot be withdrawn and will remain a part of the 8th AOPMC abstract publication in an electronic supplement to the Movement Disorders Clinical Practice journal, online edition. All submitted abstracts become the property of MDS.  
 

All accepted abstracts will be published in an electronic supplement to the Movement Disorders Clinical Practice journal online edition. All submitted abstracts become the property of MDS.

MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected. 
 

All accepted abstracts will be presented as a printed poster during designated times of the 8th AOPMC. Please check back to www.aopmc.org/abstracts for updates and specific information regarding poster size and layout. 

Daily poster presentations will be scheduled Friday and Saturday during the 2023 AOPMC. A detailed schedule, including poster set up and removal times, will be included in the abstract acceptance notification for each poster. The general poster presentation and viewing schedule can be found on the AOPMC website in December 2022.

Note: Accepted abstract presenters should plan to attend the 2023 AOPMC for the duration of the meeting, from March 17-19, 2023, as poster presentation dates are subject to change.

All abstract presenters are required to register and pay applicable registration fees to attend the 8th AOPMC. It is not mandatory that the first author is pre-registered; the presenter can be any of the contributing authors or a colleague
 

MDS is offering up to 18 Travel Grant Awards in the amount of $1,000 USD each in partial support of delegates in financial need to facilitate their travel to and participation in the 8th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress in Kolkata, India. Travel Grant recipients will also receive complimentary 8th AOPMC registration. 

To qualify, candidates must be the first author on at least one submitted abstract, and complete the official Travel Grant application incorporated into the abstract submission process. The sole means of application is within the abstract submission system. Please do not apply for a Travel Grant unless you are prepared to travel to the 8th AOPMC to present your research.

Please note: You will not be able to apply for a Travel Grant after your abstract submission is confirmed.

Only one (1) Travel Grant application per candidate will be considered for 8th AOPMC. If an individual submits multiple Travel Grant applications, only the abstract receiving the highest cumulative score will be reviewed by the AOPMC Scientific Program Committee Chairs.

Qualified applicants are not required to be a current MDS Member; however current Members do receive additional points on their cumulative application score. To apply for or renew your MDS Membership, please visit www.movementdisorders.org/Membership. 
 

The Junior Awards are given for significant contribution to clinical and basic science research in the field of Movement Disorders. Junior Award recipients will present their abstract at the Lectureship Awards Plenary Session during the 8th AOPMC, and will receive an award plaque, $1,000 USD stipend, and complimentary 8th AOPMC registration. 

Junior Awards Application Criteria:

1. Applicants must be a Junior Member of MDS or a Regular MDS Member under 40 years of age.
2. Applicants must be the first authors of their submitted abstracts.
3. Applications can only be submitted by MDS Members through the abstract submission process for the 8th AOPMC.
4. Applicants will be required to submit a statement regarding their contribution of work for their submitted abstract.